This is particularly evident in breast cancer, in which uPA and PAI-1 have been shown to be among the most potent prognostic factors described to date, with a predictive value stronger than those of patient age, tumor size, estrogen and progesterone receptors, HER-2/neu or p53 expression [17,23-25]. The gene discussed is PLAU; the disease is breast carcinoma.